Tizona Therapeutics (Series B)
Funding Details
- Awarder
- Inbox
- Date Award
- March 08, 2016
- Vertical
- Immunology
- Funding URL
- View Funding Page
- Funding Amount:
- $43,000,000
Company Info
- Founders
- Pablo J. Cagnoni, M.D.
- Company Description
- Tizona Therapeutics, Inc., is a privately held immunology company harnessing the power of the immune system to develop treatments for cancer and autoimmune disorders. Tizona's therapies are designed to regulate suppressive cells, thereby either activating the body's ability to fight cancer or preventing the immune system from attacking healthy tissues in autoimmune diseases.
- Market
- Cancer and autoimmune disorders
- Location
- South San Francisco, California, USA
- Coinvestors
- Abingworth, Amgen Business Development, Astellas Venture Management, Canaan Partners, InterWest Partners, Lightstone Ventures, MPM Capital